2,150 Shares in Hamilton Lane Incorporated (NASDAQ:HLNE) Bought by Conservest Capital Advisors Inc.

Conservest Capital Advisors Inc. purchased a new position in Hamilton Lane Incorporated (NASDAQ:HLNE) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 2,150 shares of the company’s stock, valued at approximately $244,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. GAMMA Investing LLC bought a new stake in shares of Hamilton Lane in the fourth quarter worth $48,000. New York State Common Retirement Fund increased its stake in shares of Hamilton Lane by 1.3% in the fourth quarter. New York State Common Retirement Fund now owns 17,459 shares of the company’s stock worth $1,981,000 after buying an additional 221 shares during the last quarter. Xponance Inc. bought a new stake in shares of Hamilton Lane in the fourth quarter worth $251,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Hamilton Lane by 5.6% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,831 shares of the company’s stock worth $888,000 after purchasing an additional 414 shares during the period. Finally, International Assets Investment Management LLC acquired a new position in Hamilton Lane in the fourth quarter worth $142,000. Institutional investors own 97.40% of the company’s stock.

Hamilton Lane Stock Performance

Shares of HLNE traded up $1.15 during midday trading on Friday, hitting $114.53. 160,552 shares of the stock traded hands, compared to its average volume of 200,793. Hamilton Lane Incorporated has a 1-year low of $62.86 and a 1-year high of $121.90. The firm has a market capitalization of $6.19 billion, a PE ratio of 35.24 and a beta of 1.18. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.58 and a current ratio of 2.58. The business’s 50 day moving average price is $111.80 and its two-hundred day moving average price is $105.76.

Hamilton Lane (NASDAQ:HLNE) last posted its quarterly earnings data on Tuesday, February 6th. The company reported $0.71 earnings per share for the quarter, missing the consensus estimate of $0.88 by ($0.17). The company had revenue of $125.26 million during the quarter, compared to analyst estimates of $130.47 million. Hamilton Lane had a return on equity of 28.77% and a net margin of 25.22%. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period in the previous year, the company earned $0.43 EPS. Equities research analysts predict that Hamilton Lane Incorporated will post 3.53 EPS for the current fiscal year.

Hamilton Lane Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, April 4th. Investors of record on Friday, March 15th were issued a $0.445 dividend. This represents a $1.78 annualized dividend and a yield of 1.55%. The ex-dividend date was Thursday, March 14th. Hamilton Lane’s payout ratio is currently 54.77%.

Insider Buying and Selling

In related news, major shareholder Oakville Number 2 Trust sold 55,000 shares of the company’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $108.00, for a total value of $5,940,000.00. Following the completion of the sale, the insider now owns 480,015 shares of the company’s stock, valued at $51,841,620. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 26.82% of the company’s stock.

Wall Street Analysts Forecast Growth

HLNE has been the subject of a number of research reports. Wells Fargo & Company lifted their price objective on shares of Hamilton Lane from $106.00 to $111.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 7th. Oppenheimer downgraded shares of Hamilton Lane from an “outperform” rating to a “market perform” rating in a report on Thursday, January 11th. Morgan Stanley lifted their price objective on shares of Hamilton Lane from $102.00 to $126.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. downgraded shares of Hamilton Lane from an “overweight” rating to a “neutral” rating and set a $115.00 price objective for the company. in a report on Thursday, April 11th. Finally, UBS Group lifted their price objective on shares of Hamilton Lane from $118.00 to $120.00 and gave the stock a “neutral” rating in a report on Friday, April 12th. Six equities research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $109.67.

Hamilton Lane Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.